J. Wayne Conlan - Search Results

Year	Number of Results
1996	1
2002	3
2003	3
2004	5
2005	4
2006	2
2007	3
2008	3
2009	3
2010	2
2011	5
2012	1
2015	1
2021	2
2022	1
2024	0

1

Tularemia vaccines: recent developments and remaining hurdles.

Conlan JW. Conlan JW. Future Microbiol. 2011 Apr;6(4):391-405. doi: 10.2217/fmb.11.22. Future Microbiol. 2011. PMID: 21526941 Review.

2

Francisella tularensis: a red-blooded pathogen.

Conlan JW. Conlan JW. J Infect Dis. 2011 Jul 1;204(1):6-8. doi: 10.1093/infdis/jir224. J Infect Dis. 2011. PMID: 21628652 Free PMC article. No abstract available.

3

Vaccines against Francisella tularensis--past, present and future.

Conlan JW. Conlan JW. Expert Rev Vaccines. 2004 Jun;3(3):307-14. doi: 10.1586/14760584.3.3.307. Expert Rev Vaccines. 2004. PMID: 15176947 Review.

4

Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis.

De Pascalis R, Frey B, Rice HM, Bhargava V, Wu TH, Peterson RL, Conlan JW, Sjöstedt A, Elkins KL. De Pascalis R, et al. Among authors: conlan jw. NPJ Vaccines. 2022 Aug 17;7(1):95. doi: 10.1038/s41541-022-00506-9. NPJ Vaccines. 2022. PMID: 35977964 Free PMC article.

5

Infection of mice with Francisella as an immunological model.

Conlan JW, Chen W, Bosio CM, Cowley SC, Elkins KL. Conlan JW, et al. Curr Protoc Immunol. 2011 Apr;Chapter 19:Unit 19.14. doi: 10.1002/0471142735.im1914s93. Curr Protoc Immunol. 2011. PMID: 21462168 Free PMC article.

6

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Twine SM, Fulton KM, Spika J, Ouellette M, Raven JF, Conlan JW, Krishnan L, Barreto L, Richards JC. Twine SM, et al. Among authors: conlan jw. Hum Vaccin Immunother. 2015;11(12):2923-30. doi: 10.1080/21645515.2015.1083663. Hum Vaccin Immunother. 2015. PMID: 26383909 Free PMC article.

7

Structural analysis of Francisella tularensis lipopolysaccharide.

Vinogradov E, Perry MB, Conlan JW. Vinogradov E, et al. Among authors: conlan jw. Eur J Biochem. 2002 Dec;269(24):6112-8. doi: 10.1046/j.1432-1033.2002.03321.x. Eur J Biochem. 2002. PMID: 12473106 Free article.

8

Novel Transcriptional and Translational Biomarkers of Tularemia Vaccine Efficacy in a Mouse Inhalation Model: Proof of Concept.

Liu QY, Leclerc S, Pan Y, Liu Z, Stark F, Conlan JW. Liu QY, et al. Microorganisms. 2021 Dec 26;10(1):36. doi: 10.3390/microorganisms10010036. Microorganisms. 2021. PMID: 35056485 Free PMC article.

9

Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 ΔclpB, to Prevent Tularemia.

Conlan JW, Sjöstedt A, Gelhaus HC, Fleming P, McRae K, Cobb RR, De Pascalis R, Elkins KL. Conlan JW, et al. Pathogens. 2021 Jun 23;10(7):795. doi: 10.3390/pathogens10070795. Pathogens. 2021. PMID: 34201577 Free PMC article.

10

Measurement of macrophage-mediated killing of intracellular bacteria, including Francisella and mycobacteria.

Elkins KL, Cowley SC, Conlan JW. Elkins KL, et al. Among authors: conlan jw. Curr Protoc Immunol. 2011 Apr;Chapter 14:Unit14.25. doi: 10.1002/0471142735.im1425s93. Curr Protoc Immunol. 2011. PMID: 21462167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year